Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Find effective ways to make money fast in a day. These quick cash tips can help you boost your finances instantly.
19,189 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Cathie Wood's selling moves can offer valuable lessons for investors. This article breaks down why cathie wood goes s...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
A new forecast from the most powerful claude model signals a substantial Solana rally by year-end 2026, backed by ris...
Two leading space-focused stocks pull investors in different directions. Learn how the spacemobile rocket lab: number...
A 25 percent drop often triggers fear and temptation to buy the dip. This article breaks down IBM s recent results, t...
AI memory demand sent memory-chipmakers like Micron and SK Hynix soaring. But the investing legend John Templeton wou...
A leading XRPL validator announced opposition to additional reserve reductions, reviving a divide in the community ov...
A wave of cheaper AI models is reshaping demand for hardware, boosting NVIDIA, Micron, and SanDisk as investors weigh...
Figma reports Q4 2025 revenue of $303.8 million, up 40% year over year, pushing annual revenue over the $1 billion ma...